The role of lipids in neuromodulation for psychiatric disorders: A narrative review
Open Access
- 8 February 2026
- journal article
- review article
- Published by Springer Nature in Translational Psychiatry
- Vol. 16 (1)
Abstract
Lipids are highly abundant in the brain and play key roles in membrane regulation, neurotransmission, neurogenesis, and inflammation. The same processes are involved in neuromodulation mechanisms. While neuromodulation therapies have shown promising outcomes for treatment-resistant psychiatric disorders, the factors determining individual variability in treatment response remain poorly understood. Furthermore, the potential impact of neurometabolic factors in predicting response has been largely overlooked. This narrative review aims to evaluate the role of lipids in psychiatric neuromodulation. Particularly glycerophospholipids, sphingolipids and polyunsaturated fatty acids (PUFAs) have been described as important mediators. Current evidence suggests a bidirectional relationship between lipids and neuromodulation therapies such as electroconvulsive therapy (ECT), and repetitive transcranial magnetic stimulation (rTMS). Neuromodulation effects are associated with lipid metabolism changes, including phospholipids, sphingolipids, and fatty acids. ECT is associated with an increase in lipid peroxidation and alterations of cholesterol and fatty acid levels, while rTMS is associated with normalization of sphingolipids and phospholipids levels. Solely one study investigated the relation between deep brain stimulation and lipids, showing an association with sphingolipid metabolism. To our knowledge, this is the first comprehensive review to consolidate findings on the relationship between lipids and neuromodulation. By mapping this emerging field, these findings might be a first step towards investigating whether lipids could be a potential biomarker for response prediction in the future. As most findings are preliminary, with variability across studies, further investigation is warranted and current findings should be interpreted in the context of their limitations.Keywords
Funding Information
- Universiteit van Amsterdam (T2_0920A)
- ZonMw (06360322210024)
This publication has 117 references indexed in Scilit:
- Alternations of Plasma Fatty Acids in Patients With Bipolar Depression Under Acute Treatment of rTMS Combined With Quetiapine and Mood StabilizerBrain and Behavior, 2025
- Effects of repetitive transcranial magnetic stimulation therapy on weight and lipid metabolism in patients with treatment‐resistant depression: A preliminary single‐center retrospective cohort studyNeuropsychopharmacology Reports, 2024
- Invasive and Non-invasive Neurostimulation for OCD2021
- Electroconvulsive seizures lead to lipolytic‐induced gene expression changes in mediobasal hypothalamus and decreased white adipose tissue massNeuropsychopharmacology Reports, 2021
- THE EFFICACY OF DEEP REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION OVER THE MEDIAL PREFRONTAL CORTEX IN OBSESSIVE COMPULSIVE DISORDER: RESULTS FROM AN OPEN-LABEL STUDYDepression and Anxiety, 2015
- Dynamic Regulation of Myelination in Health and DiseaseJAMA Psychiatry, 2014
- TRANSCRANIAL MAGNETIC STIMULATION (TMS) FOR MAJOR DEPRESSION: A MULTISITE, NATURALISTIC, OBSERVATIONAL STUDY OF ACUTE TREATMENT OUTCOMES IN CLINICAL PRACTICEDepression and Anxiety, 2012
- Cholesterol‐promoted synaptogenesis requires the conversion of cholesterol to estradiol in the hippocampusHippocampus, 2009
- Daily electroconvulsive shock treatment alters the inositol lipid system response in the rat hippocampusNeurochemical Research, 1994
- Reduced labeling of brain phosphatidylinositol, triacylglycerols, and diacylglycerols by [1-14C]arachidonic acid after electroconvulsive shock: Potentiation of the effect by adrenergic drugs and comparison with palmitic acid labelingNeurochemical Research, 1986